Hakimo has now raised a total of $20.5 million, including prior funding rounds led by Neotribe Ventures and Rocketship.vc.
MTN Group and Airtel Africa have struck a deal to share mobile phone network infrastructure in Uganda and Nigeria, they said ...
Juniper Networks (NYSE: JNPR), a leader in secure, AI-Native Networking, today announced a new solution purpose-built for neocloud, traditional SPs and other AI cloud providers who are deploying ...
The Israeli spyware company blacklisted over human rights concerns has hired the firm to provide strategic advice on cyber policy issues.
Learn more about whether Open Text Corporation or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, ...
Singapore, March 13: Palo Alto Networks® (NASDAQ: PANW), the global cybersecurity leader, announced today that it is deepening its commitment to the Asia-Pacific and Japan region by investing in ...
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long endeavor reached fruition in the form of a new treatment, CASGEVY ...
Shares of Vertex Pharmaceuticals Inc. VRTX rose 1.11% to $479.79 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.59% ...
In the latest quarter, 8 analysts provided ratings for Vertex VERX, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings by analysts ...
SUNNYVALE, Calif. & NEW YORK--(BUSINESS WIRE)--Juniper Networks (NYSE: JNPR), a leader in secure, AI-Native Networking, and IBM (NYSE: IBM) today announced plans to expand their collaboration ...
Vi users in Mumbai have uploaded images of 5G activation SMS messages, confirmation notifications, and the appearance of the 5G network logo on their compatible smartphones. According to a ...
Vertex has backed out of its in vivo gene editing collaboration with Verve Therapeutics before reaching the clinic. Verve, which attributed Vertex’s action to its changing R&D priorities, is ...